Adebrelimab Biosimilar - Research Grade

Human

PD-1

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2756

Q15116

Blue ice

Few targets have been studied as intensively as PD-1, the inhibitory checkpoint that suppresses activated T cells in cancer immunology research. This recombinant anti-human PD-1 monoclonal is an unconjugated, non-therapeutic analog of adebrelimab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for heavy-usage and high-throughput laboratories. Applications include functional assays, receptor-blockade and effector-T-cell studies, reproducible controls, and in vivo immuno-oncology models, with the consistency required for extended, high-volume experimental work.

Detects human PD-1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks